Takeda Pharmaceutical (NYSE:TAK - Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.34 by $0.08, Zacks reports. Takeda Pharmaceutical had a net margin of 4.53% and a return on equity of 9.39%. Takeda Pharmaceutical updated its FY 2024 guidance to 3.330-3.330 EPS.
Takeda Pharmaceutical Trading Down 1.0 %
NYSE:TAK traded down $0.14 during trading hours on Monday, reaching $13.26. The company's stock had a trading volume of 1,692,361 shares, compared to its average volume of 2,081,516. The firm has a 50-day simple moving average of $13.31 and a 200-day simple moving average of $13.89. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.72 and a current ratio of 1.31. Takeda Pharmaceutical has a 1 year low of $12.57 and a 1 year high of $15.08. The firm has a market capitalization of $42.18 billion, a price-to-earnings ratio of 33.14, a PEG ratio of 0.23 and a beta of 0.51.
About Takeda Pharmaceutical
(
Get Free Report)
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.
Featured Stories
Before you consider Takeda Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Takeda Pharmaceutical wasn't on the list.
While Takeda Pharmaceutical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
